4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0001140361-07-008160
CIK 0000882104operating
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 12:37 PM ET
Size
22.9 KB
Accession
0001140361-07-008160
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Exercise/Conversion
Common Stock
2007-04-20$17.13/sh+645$11,049→ 645 total - Sale
Common Stock
2007-04-20$23.87/sh−64$1,528→ 581 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2007-04-20−645→ 25,195 totalExercise: $17.13Exp: 2013-07-20→ Common Stock (645 underlying) - Sale
Common Stock
2007-04-20$23.98/sh−133$3,189→ 384 total
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Option vests with respect to approximately 645 shares per month and 7 shares remained exercisable immediately after this transaction. Only vested options are exercisable
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 12:37 PM ET
- Size
- 22.9 KB